EpilepsyNCT02263274
Direct Cortical Measurement of the Intensity and Pattern of Current Flow Produced by TDCS
A study testing Transcranial Direct Current Stimulation (TDCS) in people with Epilepsy, run by NYU Langone Health at 1 site in United States.
Trial summary
The primary study objective is to measure the electrical fields evoked by tDCS using subjects who have implanted intracranial electrodes as part of their evaluation for epilepsy surgery. The measurements obtained in these subjects and their brain MRI will be employed to validate existing mathematical models. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Epilepsy
- What is being tested?
- Transcranial Direct Current Stimulation (TDCS)
- Type of treatment
- Medical device
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 30 participants
- Where
- 1 siteUnited States
- Study dates
- Nov 2013to 9 Jan 2026
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Subjects for this study will be recruited from patients undergoing routine intracranial electrode placement as part of the evaluation for surgical treatment of medically refractory epilepsy. Inclusion criteria include:
- Age ≥ 18 years
- Placement of intracranial electrode arrays (grid, strip and or depth electrodes) for seizure focus localization and/or mapping of eloquent cortex
- Able to provide written informed consent
- English-speaking patients only
Who cannot join
- Cognitive impairment (Intelligence Quotient <70)
- Facial or forehead skin breakdown that would interfere with surface electrode placement
- Contraindication to MRI
- Known adhesive allergy
- Space occupying intracranial pathology including brain tumor, ateriovenous malformation, cavernous malformation, prior surgical resection or significant encephalomalcia that would create unknown tissue inhomogeneity that cannot be accurately modeled.
- Subjects who have had an electrographic or clinical seizure within one hour prior to the stimulation procedure
Trial locations and contacts
1 site in 1 country.
About this study
The primary study objective is to measure the electrical fields evoked by tDCS using subjects who have implanted intracranial electrodes as part of their evaluation for epilepsy surgery. The measurements obtained in these subjects and their brain MRI will be employed to validate existing mathematical models.
In the future, these refined models can be used to target tDCS to predetermined brain regions in healthy and subjects and patient populations. As described above in the safety section, the intensities of stimulation applied in this project are not expected to produce changes in brain function, are below intensities commonly applied in clinical trials, and fall well below safety limits suggested by animal studies.
Read the detailed description
Noninvasive brain stimulation (NBS) represents a promising set of tools for neurotherapeutics and rehabilitation. In a literature search, NBS has been tested for over seventy neurologic and psychiatric conditions. NBS may complement existing medical treatments, especially for neurologic indications without suitable pharmacotherapies (e.g. tinnitus, dyskinesias) or for patients with pharmaco-resistant illness (e.g. intractable epilepsy, severe depression).
In particular, transcranial direct current stimulation (tDCS) modulates brain activity by delivering low intensity unidirectional current through the scalp. Rather than induce action potentials, tDCS modulates resting neuronal transmembrane potential to influence brain plasticity. Moreover, from a pragmatic perspective, tDCS' benefits include its low cost, portability, and ease of use. Furthermore, tDCS can easily be combined with other interventions such as mental imagery, computerized cognitive interventions, or robot-assisted motor activity.
Current physiological understanding of how TDCS affects brain plasticity at a synaptic, cellular, and a network level is limited. Experimentally, spontaneous neuronal firing activity under the anode generally increases, while firing activity under the cathode decreases, although the precise effects probably depend on the orientation of the axons to the electric field (Nitsche and Paulus, 2000, Bindman et al., 1964, Creutzfeldt et al., 1962, Purpura and McMurtry, 1965). The neuromodulatory effects of tDCS have also been broadly attributed to LTP- and LTD-like mechanisms of synaptic plasticity, involving modulation of NMDA-receptor activity, and sodium and calcium channel activity (Hattori et al., 1990, Islam et al., 1995, Liebetanz et al., 2002). Furthermore, functional neuroimaging studies have revealed both local and distant network effects induced by tDCS, probably mediated by interneuronal circuits (Lefaucheur, 2008).
Advancing the investigators mechanistic understanding of how tDCS affects cortical excitability on a local and distributed level is necessary to (1) customize stimulation parameters (e.g. electrode size, positioning, current intensity and duration) to precisely target brain regions and maximize therapeutic outcomes, (2) confirm safety outcomes for vulnerable patient populations (e.g. children, patients with skull defects and implanted hardware). Previously, patients with a scalp or skull defect have been excluded from stimulation (Bikson, 2012) protocols because of a theoretical risk of current shunting through highly conductive CSF collections. However patients with penetrating brain injury, stroke, or previous brain surgery are precisely those who may most benefit from these technologies.
Computational models using finite element methods (FEM) aim to determine the pattern and intensity of current flow through the brain by incorporating both (1) stimulation parameters and (2) patient characteristics such as underlying anatomy and tissue properties (e.g. size and position of skull defect relative to electrode configuration) (Bikson 2012). For example, one computational model incorporating electrode configuration and skull defect size and properties (Datta et al., 2010) predicts that the majority of electrode configurations surrounding the skull defect (with the exception of stimulating directly on top of a small skull defect) will not significantly increase the peak cortical electrical field intensity. Rather, current is directed to the edges of the bony defect, which may be counterproductive to therapeutic goals. Another computational case study on a stroke patient demonstrated that a relatively conductive stroke lesion concentrated current in the perilesional areas, and that placement of the reference electrode (e.g. right should, right mastoid, right orbitofrontal, and contralateral hemisphere) significantly altered the path of greatest current flow (Datta et al., 2011).
Yet, these modeling predictions are limited in their clinical application, as experimental validation is necessary. Quantitative determination of the electrical field at the neural tissue level is required to establish efficacy and safety for a given individual (Bikson 2012). To the investigators knowledge, there are no published studies that have empirically confirmed the predicted patterns and current flow intensities predicted by these models. This proposed experimental study represents the first-in-kind to quantify voltage intensities, as measured at the brain surface, in response to various stimulation parameters, and will represent a significant advance in the field of noninvasive neurostimulation
- Conditions
- Epilepsy
- Being tested
- Transcranial Direct Current Stimulation (TDCS)
- Medical subject headings
- Epilepsy
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Transcranial Direct Current Stimulation (TDCS)Device
Also called TDCS
Conventional tDCS and low-frequency tACS are commonly administered at a current intensity of 2 mA or less
| Study group | Role | What they receive |
|---|---|---|
| Direct Cortical Measurement | Experimental | Consented subjects will also have transcranial electrodes applied at four extracranial sites, below the sterile dressing and distant from the surgical skull defect. The four electrodes will be placed in uniform positions based on the standard 10-10 electrode system, at the temples bilaterally (positions F9 and F10) and at the occiput bilaterally (positions PO9 and PO10). Subjects will be stimulated according to a predetermined set of parameters which fall well within empirically and computationally determined safety thresholds, as discussed above. The entire stimulation protocol is described in detail in section 5, and is anticipated to last no longer than 30 minutes. Receives: Device: Transcranial Direct Current Stimulation (TDCS) |
What is being measured
The primary outcome is the main question the study is designed to answer.
Current Intensity
MRI
Measured: 24 hour Post Op
Total charge (stimulation intensity x duration of stimulation in coulombs
MRI
Measured: 24 Hour Post Op
Total electrode charge density (total charge/electrode area in coloumbs/meters2) as measured at various subdural and depth electrode recording sites
MRI
Measured: 24 Hour Post Op
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted13 Oct 2014 (estimated)
- Study startNov 2013
- Primary completion9 Jan 2026
- Study completion9 Jan 2026
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for EpilepsyStudies of the same condition, open and under way.
- More trials run by NYU Langone HealthThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Basic science
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Enrolment
- 30 participants (actual)
Sponsor and investigators
- Lead sponsor
- NYU Langone Health
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Anli Liu, MD, Principal investigator, NYU Langone Health
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT02263274
- Sponsor's protocol ID
- 13-01171
- Status last verified
- Feb 2026
- First submitted
- 8 Oct 2014
- Last updated
- 27 Feb 2026
- Results posted
- No
- Data monitoring committee
- Yes
Study at a glance
From the registry record, last updated by the sponsor on 27 Feb 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Direct Cortical Measurement of the Intensity and Pattern of Current Flow Produced by TDCS
- ClinicalTrials.gov ID
- NCT02263274
- Acronym / sponsor ID
- 13-01171
- Conditions
- Epilepsy
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 30 participants (actual)
- Lead sponsor
- NYU Langone HealthUniversity, hospital or other
- Study start
- Nov 2013 (actual)
- Primary completion
- 9 Jan 2026 (actual)
- Study completion
- 9 Jan 2026 (actual)
- First posted
- 13 Oct 2014 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The primary study objective is to measure the electrical fields evoked by tDCS using subjects who have implanted intracranial electrodes as part of their evaluation for epilepsy surgery. The measurements obtained in these subjects and their brain MRI will be employed to validate existing mathematical models.
In the future, these refined models can be used to target tDCS to predetermined brain regions in healthy and subjects and patient populations. As described above in the safety section, the intensities of stimulation applied in this project are not expected to produce changes in brain function, are below intensities commonly applied in clinical trials, and fall well below safety limits suggested by animal studies.
Detailed description
Noninvasive brain stimulation (NBS) represents a promising set of tools for neurotherapeutics and rehabilitation. In a literature search, NBS has been tested for over seventy neurologic and psychiatric conditions. NBS may complement existing medical treatments, especially for neurologic indications without suitable pharmacotherapies (e.g. tinnitus, dyskinesias) or for patients with pharmaco-resistant illness (e.g. intractable epilepsy, severe depression).
In particular, transcranial direct current stimulation (tDCS) modulates brain activity by delivering low intensity unidirectional current through the scalp. Rather than induce action potentials, tDCS modulates resting neuronal transmembrane potential to influence brain plasticity. Moreover, from a pragmatic perspective, tDCS' benefits include its low cost, portability, and ease of use. Furthermore, tDCS can easily be combined with other interventions such as mental imagery, computerized cognitive interventions, or robot-assisted motor activity.
Current physiological understanding of how TDCS affects brain plasticity at a synaptic, cellular, and a network level is limited. Experimentally, spontaneous neuronal firing activity under the anode generally increases, while firing activity under the cathode decreases, although the precise effects probably depend on the orientation of the axons to the electric field (Nitsche and Paulus, 2000, Bindman et al., 1964, Creutzfeldt et al., 1962, Purpura and McMurtry, 1965). The neuromodulatory effects of tDCS have also been broadly attributed to LTP- and LTD-like mechanisms of synaptic plasticity, involving modulation of NMDA-receptor activity, and sodium and calcium channel activity (Hattori et al., 1990, Islam et al., 1995, Liebetanz et al., 2002). Furthermore, functional neuroimaging studies have revealed both local and distant network effects induced by tDCS, probably mediated by interneuronal circuits (Lefaucheur, 2008).
Advancing the investigators mechanistic understanding of how tDCS affects cortical excitability on a local and distributed level is necessary to (1) customize stimulation parameters (e.g. electrode size, positioning, current intensity and duration) to precisely target brain regions and maximize therapeutic outcomes, (2) confirm safety outcomes for vulnerable patient populations (e.g. children, patients with skull defects and implanted hardware). Previously, patients with a scalp or skull defect have been excluded from stimulation (Bikson, 2012) protocols because of a theoretical risk of current shunting through highly conductive CSF collections. However patients with penetrating brain injury, stroke, or previous brain surgery are precisely those who may most benefit from these technologies.
Computational models using finite element methods (FEM) aim to determine the pattern and intensity of current flow through the brain by incorporating both (1) stimulation parameters and (2) patient characteristics such as underlying anatomy and tissue properties (e.g. size and position of skull defect relative to electrode configuration) (Bikson 2012). For example, one computational model incorporating electrode configuration and skull defect size and properties (Datta et al., 2010) predicts that the majority of electrode configurations surrounding the skull defect (with the exception of stimulating directly on top of a small skull defect) will not significantly increase the peak cortical electrical field intensity. Rather, current is directed to the edges of the bony defect, which may be counterproductive to therapeutic goals. Another computational case study on a stroke patient demonstrated that a relatively conductive stroke lesion concentrated current in the perilesional areas, and that placement of the reference electrode (e.g. right should, right mastoid, right orbitofrontal, and contralateral hemisphere) significantly altered the path of greatest current flow (Datta et al., 2011).
Yet, these modeling predictions are limited in their clinical application, as experimental validation is necessary. Quantitative determination of the electrical field at the neural tissue level is required to establish efficacy and safety for a given individual (Bikson 2012). To the investigators knowledge, there are no published studies that have empirically confirmed the predicted patterns and current flow intensities predicted by these models. This proposed experimental study represents the first-in-kind to quantify voltage intensities, as measured at the brain surface, in response to various stimulation parameters, and will represent a significant advance in the field of noninvasive neurostimulation
Study design
- Primary purpose
- Basic science
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Direct Cortical Measurement | Experimental | Device: Transcranial Direct Current Stimulation (TDCS)Consented subjects will also have transcranial electrodes applied at four extracranial sites, below the sterile dressing and distant from the surgical skull defect. The four electrodes will be placed in uniform positions based on the standard 10-10 electrode system, at the temples bilaterally (positions F9 and F10) and at the occiput bilaterally (positions PO9 and PO10). Subjects will be stimulated according to a predetermined set of parameters which fall well within empirically and computationally determined safety thresholds, as discussed above. The entire stimulation protocol is described in detail in section 5, and is anticipated to last no longer than 30 minutes. |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (5 listed)
- Subjects for this study will be recruited from patients undergoing routine intracranial electrode placement as part of the evaluation for surgical treatment of medically refractory epilepsy. Inclusion criteria include:
- Age ≥ 18 years
- Placement of intracranial electrode arrays (grid, strip and or depth electrodes) for seizure focus localization and/or mapping of eloquent cortex
- Able to provide written informed consent
- English-speaking patients only
Key exclusion criteria (6 listed)
- Cognitive impairment (Intelligence Quotient <70)
- Facial or forehead skin breakdown that would interfere with surface electrode placement
- Contraindication to MRI
- Known adhesive allergy
- Space occupying intracranial pathology including brain tumor, ateriovenous malformation, cavernous malformation, prior surgical resection or significant encephalomalcia that would create unknown tissue inhomogeneity that cannot be accurately modeled.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Transcranial Direct Current Stimulation (TDCS)Also: TDCSConventional tDCS and low-frequency tACS are commonly administered at a current intensity of 2 mA or less | Device | Direct Cortical Measurement |
Primary outcome
Current Intensity
Time frame: 24 hour Post Op
MRI
Total charge (stimulation intensity x duration of stimulation in coulombs
Time frame: 24 Hour Post Op
MRI
Total electrode charge density (total charge/electrode area in coloumbs/meters2) as measured at various subdural and depth electrode recording sites
Time frame: 24 Hour Post Op
MRI
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 27 Feb 2026.
Related trials for Epilepsy
Not yet recruiting
Clinical Trial of SEEG for Drug-resistant Epilepsy
Drug-Resistant Epilepsy
RecruitingPhase 3
Investigate Efficacy and Safety of Carisbamate as Adjunctive Treatment for Seizures Associated With LGS in Children and Adults
Seizures, Lennox Gastaut Syndrome
RecruitingPhase 3
Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures
Focal Seizure, Epilepsy
Active, not recruitingObservational study
Transforming Research and Clinical Knowledge in Traumatic Brain Injury Epileptogenesis Project (TRACK-TBI EPI)
Traumatic Brain Injury, Post-traumatic Epilepsy
RecruitingPhase 3
Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures FOCUS-1
Focal Seizure, Epilepsy
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Anli Liu, MD principal investigator
NYU Langone Health
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Transcranial Direct Current Stimulation (TDCS) in people with Epilepsy, run by NYU Langone Health at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 27 Feb 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Current Intensity (time frame: 24 hour Post Op). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 Feb 2026.